Evaluation of Hyperemia With the Use of Ocular Prostaglandin Analogues

PHASE4CompletedINTERVENTIONAL

Enrollment

106

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

July 31, 2008

Study Completion Date

September 30, 2008

Conditions

Open Angle GlaucomaOcular Hypertension

Interventions

DRUG

Bimatoprost 0.03%

bimatoprost 0.03%, 1 drop nightly for 3 months

DRUG

travoprost 0.004%

travoprost 0.004% eye drops, 1 drop nightly for 3 months

DRUG

latanoprost 0.005% eye drops

latanoprost 0.005%, 1 drop nightly for 3 months

Trial Locations (1)

San Diego